NVP Associates

Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are MBX, Avalyn Pharma, OMDA, ZBIO, SNOW, and represent 98.73% of NVP Associates's stock portfolio.
  • Added to shares of these 3 stocks: Avalyn Pharma (+$75M), SNOW (+$29M), ONDS.
  • Started 3 new stock positions in SNOW, ONDS, Avalyn Pharma.
  • Reduced shares in these 1 stock: BLLN (-$41M).
  • Sold out of its position in BLLN.
  • NVP Associates was a net buyer of stock by $64M.
  • NVP Associates has $328M in assets under management (AUM), dropping by 86.28%.
  • Central Index Key (CIK): 0001545692

Tip: Access up to 7 years of quarterly data

Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for NVP Associates

NVP Associates holds 7 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mbx Biosciences (MBX) 35.9 $118M 2.1M 55.20
 View chart
Avalyn Pharmaceuticals Com Shs 22.8 $75M NEW 2.3M 32.92
 View chart
Omada Health (OMDA) 16.9 $56M 2.5M 21.95
 View chart
Zenas Biopharma (ZBIO) 14.2 $47M 1.8M 25.38
 View chart
Snowflake Com Shs (SNOW) 8.9 $29M NEW 115k 254.50
 View chart
Grove Collaborative Hold Com Cl A (GROV) 1.2 $4.0M 3.2M 1.25
 View chart
Ondas Com New (ONDS) 0.0 $129k NEW 16k 8.24
 View chart

Past Filings by NVP Associates

SEC 13F filings are viewable for NVP Associates going back to 2022